Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

about

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

Item

http://www.wikidata.org/entity/Q42343446

description

2015 nî lūn-bûn

@nan

2015年の論文

@ja

2015年論文

@yue

2015年論文

@zh-hant

2015年論文

@zh-hk

2015年論文

@zh-mo

2015年論文

@zh-tw

2015年论文

@wuu

2015年论文

@zh

2015年论文

@zh-cn

name

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

@en

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

@nl

type

Item

label

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

@en

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

@nl

prefLabel

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

@en

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

@nl

P1476

Menahydroquinone-4 Prodrug: A Promising Candidate Anti-Hepatocellular Carcinoma Agent.

@en

P2093

Daisuke Watase

http://www.w3.org/2001/XMLSchema#string

Jiro Takata

http://www.w3.org/2001/XMLSchema#string

Kazuhisa Matsunaga

http://www.w3.org/2001/XMLSchema#string

Mariko Kusuda

http://www.w3.org/2001/XMLSchema#string

Munechika Enjoji

http://www.w3.org/2001/XMLSchema#string

Nami Nagata-Akaho

http://www.w3.org/2001/XMLSchema#string

Yoshiharu Karube

http://www.w3.org/2001/XMLSchema#string

P2860

Human vitamin K 2,3-epoxide reductase complex subunit 1-like 1 (VKORC1L1) mediates vitamin K-dependent intracellular antioxidant function

Cyclin D1 functions in cell migration

NF-kappaB and IKK as therapeutic targets in cancer

Vitamin K-dependent biosynthesis of gamma-carboxyglutamic acid

NF-kappaB at the crossroads of life and death

Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients.

Vitamin K2 supplementation improves hip bone geometry and bone strength indices in postmenopausal women

The vitamin K cycle.

Role of vitamin K2 in preventing the recurrence of hepatocellular carcinoma after curative treatment: a meta-analysis of randomized controlled trials

Clinical and molecular insights into the hepatocellular carcinoma tumour marker des-γ-carboxyprothrombin.

P304

150-158

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.3390/DISEASES3030150

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P577

2015-07-22T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

282199168

http://www.w3.org/2001/XMLSchema#string

P698

28943616

http://www.w3.org/2001/XMLSchema#string

P932

5548248

http://www.w3.org/2001/XMLSchema#string